PENTACARINAT

Pre-Launch

pentamidine isethionate

ANDAINJECTIONINJECTABLE

Lifecycle

Pre-Launch

Data completeness

2/8 — Basic

PENTACARINAT (pentamidine isethionate) by R-Pharm US is clinical pharmacology pentamidine isethionate, an aromatic diamidine, is known to have activity against pneumocystis carinii . Approved for pneumonia due to pneumocystis carinii.

Drug data last refreshed 1mo ago

Mechanism of Action

CLINICAL PHARMACOLOGY Pentamidine isethionate, an aromatic diamidine, is known to have activity against Pneumocystis carinii . The mode of action of pentamidine is not fully understood. In vitro studies indicate that the drug interferes with protozoal nuclear metabolism by inhibition of DNA, RNA,…

Worked on PENTACARINAT at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

PENTACARINAT

Mechanism of Action

Indications (1)